<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04595591</url>
  </required_header>
  <id_info>
    <org_study_id>2020ZSLYEC-182</org_study_id>
    <nct_id>NCT04595591</nct_id>
  </id_info>
  <brief_title>Observation of Propofol Titration at Different Speeds</brief_title>
  <acronym>OPTDS</acronym>
  <official_title>Effects of Propofol Titration at Different Speeds on Hemodynamics and Stress During General Anesthesia Induction</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>SanQing Jin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sixth Affiliated Hospital, Sun Yat-sen University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Propofol is one of the most widely used anesthetics for its fast onset and quick elimination.&#xD;
      The conventional speed of its induction dose often causes severe hemodynamics fluctuations&#xD;
      with hypotension and arrhythmia. The recommended dosage on the drug insert comes from group&#xD;
      pharmacokinetic studies which does not apply to the specific situation of every patient, so&#xD;
      the investigators emphasize individualized medication. The investigators have observed the&#xD;
      titration of propofol in general anesthesia induction, and found that the dosage was less and&#xD;
      the hemodynamics was becoming more stable. At the same time, the investigators found that the&#xD;
      hemodynamics still has obvious fluctuations in the titration of the administration rate&#xD;
      recommended in the instructions. The investigators intend to further compare the effects of&#xD;
      propofol titration administration at different rates for hemodynamics and stress during the&#xD;
      induction period of general anesthesia, and find a safer and more appropriate rate of&#xD;
      administration.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Based on the recommended dosing speed in the propofol instructions, this research protocol&#xD;
      further reduces the dosing speed (40 mg administered every 10 seconds), and sets three&#xD;
      different titration dosing speeds: group I 2 mg/kg/min; group II 1 mg /kg/min; group III 0.5&#xD;
      mg/kg/min. The program is calculated by statistics, and it will be planned to enroll 276&#xD;
      participants undergoing elective surgery under general anesthesia with oral endotracheal&#xD;
      intubation, and randomly divided into 3 groups according to a random number table, with 92&#xD;
      cases in each group. When participants reach the titration endpoint (OAAS score 1 point)&#xD;
      during the titration of propofol in the induction, the investigators stop the dosing and&#xD;
      switch to a maintenance dose, and give rocuronium 0.15 mg/kg and remifentanil 2 ug/kg; 2&#xD;
      minutes later the chief anesthetist performs tracheal intubation. The investigators will&#xD;
      observe hemodynamics changes and brain electrical activity throughout the process, and adjust&#xD;
      the drugs according to the blood pressure to make the hemodynamics as stable as possible.&#xD;
&#xD;
      After confirming the successful tracheal intubation, the investigators will give participants&#xD;
      machine-controlled ventilation, and the total intravenous anesthesia (TIVA) will be given&#xD;
      with propofol, remifentanil, and cis-atracurium. During the operation, remifentanil will be&#xD;
      injected with a constant rate of 0.2ug/kg/min, and propofol will be injected with a&#xD;
      fluctuating rate of 2-8mg/kg/h (the pump injection rate will be adjusted according to blood&#xD;
      pressure and BIS, and the rate of remifentanil can be adjusted if necessary) to maintain BIS&#xD;
      between 40-60.Fluid therapy will be performed according to the participants' hemodynamics and&#xD;
      intraoperative conditions. After extubation, participants will be sent to the postoperative&#xD;
      recovery room; a follow-up visit will be performed the next day, and a telephone return visit&#xD;
      will be performed on the 30th day.&#xD;
&#xD;
      The investigators record the visual analogue scale(VAS) score for preoperative anxiety of&#xD;
      each participant, bispectral index (BIS) and hemodynamics of patients when participants reach&#xD;
      different stages of sedation as determined by the Observer's Assessment of Alertness/Sedation&#xD;
      Scale (OAAS) score, and the lowest value and specific time of mean blood pressure(MBP) and&#xD;
      BIS during induction of anesthesia；the investigators record various parameters at the&#xD;
      following time points(10 minutes after entering the operating room before propofol&#xD;
      administration, every minute after administration until intubation, immediately after&#xD;
      tracheal intubation, and 1, 2, 4, 6, 8, 10, 20 min after intubation), and parameters include:&#xD;
      systolic blood pressure(SBP) , diastolic blood pressure(DBP), MBP, heart rate(HR),&#xD;
      electrocardiogram ST-T changes (V1), BIS, cardiac function parameters (heart rate&#xD;
      variability(HRV), stroke volume (SV), stroke index(SVI), cardiac output (CO), cardiac&#xD;
      index(CI) ), oxygen delivery parameters (oxygen delivery (DO2), oxygen delivery index&#xD;
      (DO2I)), peripheral vascular resistance parameters (systemic vascular resistance (SVR),&#xD;
      systemic vascular resistance index (SVRI)), volume parameters (stroke volume variation(SVV),&#xD;
      pulse pressure variation (PPV), increase in stroke volume(△SV)); the investigators record the&#xD;
      time for each participant reach the titration endpoint and the amount of propofol used, the&#xD;
      time from the start of induction to the completion of the tracheal intubation and the amount&#xD;
      of propofol, and the total amount of propofol during the operation.&#xD;
&#xD;
      The investigators record invasive blood during the trial, and use cameras to video the entire&#xD;
      process of anesthesia induction.&#xD;
&#xD;
      The 11-30th participants in each group will be given arterial blood samples at 1, 3, 5, and 7&#xD;
      minutes after the administration of propofol to measure the blood concentration of propofol;&#xD;
      when rocuronium is given and 30 seconds after the completion of tracheal intubation, venous&#xD;
      blood will be drawn to measure the catecholamine concentration; ten cases of propofol with&#xD;
      high, medium and low sensitivity will be selected for transcriptome RNA sequencing; Single&#xD;
      nucleotide polymorphism（SNP） analysis of propofol-related genes in special cases.&#xD;
&#xD;
      During the induction period, the investigators will monitor EEG of the left and right&#xD;
      frontal, temporal and occipital lobes, and analyze the power spectrum of β, α, θ, and σ brain&#xD;
      waves; observe the pupil reflex and auditory evoked potential(brain stem auditory evoked&#xD;
      potentials(BAEP): the incubation period and amplitude of III, V ; middle latency auditory&#xD;
      evoked potentials（MLAEP）: the incubation period and amplitude of Pa, Nb) before induction ,&#xD;
      when the titration endpoint reaches and after finishing intubation.&#xD;
&#xD;
      Blind design:&#xD;
&#xD;
      The observer performs pre-entry screening, and does not know the group of participants during&#xD;
      the induction process. The anesthesia nurse receives the experiment envelope in advance,&#xD;
      adjusts the infusion pump according to the group, and adjusts the pump to the position facing&#xD;
      away from the observer and the chief anesthetist. The chief anesthetist communicates with&#xD;
      patients and performs OAAS scores scoring. When the titration endpoint reaches, the&#xD;
      anesthesia nurse will stop propofol administer and shift to the maintenance dose, following&#xD;
      the observer's order to add vasoactive drugs or propofol during the induction process, and do&#xD;
      not participate in the postoperative follow-up work. The chief anesthetist (working for more&#xD;
      than 3 years) is responsible for assisted ventilation and tracheal intubation. The&#xD;
      anesthesiologist in the resuscitation room, the patient, and the post-operative return&#xD;
      visitor do not know the group of the participant.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 20, 2020</start_date>
  <completion_date type="Anticipated">February 14, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 14, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean blood pressure(MBP)</measure>
    <time_frame>During the procedure of anesthesia induction</time_frame>
    <description>Relative change of MBP(decreased more than 30%) in the three groups</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stroke Volume (SV)</measure>
    <time_frame>During the procedure of anesthesia induction</time_frame>
    <description>Relative change of SV (ml/beat) in the three groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac Output (CO)</measure>
    <time_frame>During the procedure of anesthesia induction</time_frame>
    <description>Relative change of CO (litre/min) in the three groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systemic Vascular Resistance (SVR)</measure>
    <time_frame>During the procedure of anesthesia induction</time_frame>
    <description>Relative change of SVR (dynes-sec/cm5/m2) in the three groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Catecholamine</measure>
    <time_frame>During the procedure of anesthesia induction</time_frame>
    <description>Concentration of catecholamines in venous blood before and after tracheal intubation in the three groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Plasma concentration change curves</measure>
    <time_frame>During the procedure of anesthesia induction</time_frame>
    <description>Plasma concentration change curves of propofol in the three groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The relative level of mRNA in serum</measure>
    <time_frame>Baseline</time_frame>
    <description>Expression differences of RNA sequences in groups of high, middle and low propofol sensitivity through bioinformatics analysis.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain electrical activity</measure>
    <time_frame>During the procedure of anesthesia induction</time_frame>
    <description>Differences of brain electrical activity (EEG, AEP)in the three groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The dosage of propofol</measure>
    <time_frame>Through anesthesia completion, an average of 3 hours.</time_frame>
    <description>The dosage of propofol (reach the end of the titration, complete the tracheal intubation ) and intraoperative maintenance dosage in the three groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Induction time</measure>
    <time_frame>Through anesthesia completion, an average of 3 hours.</time_frame>
    <description>Induction time in the three groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recovery time</measure>
    <time_frame>Through anesthesia completion, an average of 3 hours.</time_frame>
    <description>Postoperative recovery time in the three groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The occurrence of important cardiovascular events</measure>
    <time_frame>One month after finish operation</time_frame>
    <description>The occurrence of important cardiovascular events during the perioperative period</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">276</enrollment>
  <condition>Anesthesia, General</condition>
  <condition>Hemodynamics</condition>
  <arm_group>
    <arm_group_label>Group Ⅰ</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>titration dosing speeds of propofol at 2mg/kg/min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Ⅱ</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>titration dosing speeds of propofol at 1mg/kg/min</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group III</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>titration dosing speeds of propofol at 0.5mg/kg/min</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>2mg/kg/min</intervention_name>
    <description>titration dosing speeds of propofol at 2mg/kg/min</description>
    <arm_group_label>Group Ⅰ</arm_group_label>
    <other_name>Remifentanil 2ug/kg</other_name>
    <other_name>Rocuronium 1.5mg/kg</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>1mg/kg/min</intervention_name>
    <description>titration dosing speeds of propofol at 1mg/kg/min</description>
    <arm_group_label>Group Ⅱ</arm_group_label>
    <other_name>Remifentanil 2ug/kg</other_name>
    <other_name>Rocuronium 1.5mg/kg</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.5mg/kg/min</intervention_name>
    <description>titration dosing speeds of propofol at 0.5mg/kg/min</description>
    <arm_group_label>Group III</arm_group_label>
    <other_name>Remifentanil 2ug/kg</other_name>
    <other_name>Rocuronium 1.5mg/kg</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age 18-60 Years old&#xD;
&#xD;
          2. Elective surgery for general anesthesia through oral tracheal intubation and surgery&#xD;
             is expected to last more than 2 hours&#xD;
&#xD;
          3. The American Society of Anesthesiologists(ASA) grade is I or II, and the cardiac&#xD;
             function is 1-2;&#xD;
&#xD;
          4. Body mass index (BMI) 18-30 kg/m2;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients have severe heart, lung, liver, and kidney diseases (heart function grade&gt;3 /&#xD;
             respiratory failure / liver failure / renal failure)&#xD;
&#xD;
          2. Patients with arrhythmia: sinus bradycardia (ventricular rate &lt;60 beats/min), atrial&#xD;
             fibrillation, atrial flutter, atrioventricular block, frequent ventricular premature,&#xD;
             multi-source ventricular premature, ventricular premature R on T, Ventricular&#xD;
             fibrillation and ventricular flutter.&#xD;
&#xD;
          3. Patients who are expected to be difficult to intubate, hypoalbuminemia(albumin is less&#xD;
             than 35g/L), hypertension and diabetes;&#xD;
&#xD;
          4. Patients with a higher risk of reflux and aspiration, such as full stomach,&#xD;
             gastrointestinal obstruction, gastroparesis, and pregnant women;&#xD;
&#xD;
          5. Patients have schizophrenia, epilepsy, Parkinson's disease, intellectual disability,&#xD;
             hearing impairment, abnormal EEG, etc.;&#xD;
&#xD;
          6. Patients who take sedative and analgesic drugs for a long time;&#xD;
&#xD;
          7. Patients who are allergic to propofol or its fat emulsion;&#xD;
&#xD;
          8. Patients who are participating in other clinical trials, and who refuse to sign&#xD;
             informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>SanQing Jin, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>the Sixth Affiliated Hospital, Sun Yat-sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>SanQing Jin, MD</last_name>
    <phone>0086-13719366863</phone>
    <email>sanqingjin@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>LiHong Chen, MD</last_name>
    <phone>0086-13760779697</phone>
    <email>lihongchenk8@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>the Sixth Affiliated Hospital, Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>SanQing Jin, MD</last_name>
      <phone>0086-13719366863</phone>
      <email>sanqingjin@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Jor O, Maca J, Koutna J, Gemrotova M, Vymazal T, Litschmannova M, Sevcik P, Reimer P, Mikulova V, Trlicova M, Cerny V. Hypotension after induction of general anesthesia: occurrence, risk factors, and therapy. A prospective multicentre observational study. J Anesth. 2018 Oct;32(5):673-680. doi: 10.1007/s00540-018-2532-6. Epub 2018 Jul 19.</citation>
    <PMID>30027443</PMID>
  </reference>
  <reference>
    <citation>de Wit F, van Vliet AL, de Wilde RB, Jansen JR, Vuyk J, Aarts LP, de Jonge E, Veelo DP, Geerts BF. The effect of propofol on haemodynamics: cardiac output, venous return, mean systemic filling pressure, and vascular resistances. Br J Anaesth. 2016 Jun;116(6):784-9. doi: 10.1093/bja/aew126.</citation>
    <PMID>27199311</PMID>
  </reference>
  <reference>
    <citation>Walsh M, Devereaux PJ, Garg AX, Kurz A, Turan A, Rodseth RN, Cywinski J, Thabane L, Sessler DI. Relationship between intraoperative mean arterial pressure and clinical outcomes after noncardiac surgery: toward an empirical definition of hypotension. Anesthesiology. 2013 Sep;119(3):507-15. doi: 10.1097/ALN.0b013e3182a10e26.</citation>
    <PMID>23835589</PMID>
  </reference>
  <reference>
    <citation>Südfeld S, Brechnitz S, Wagner JY, Reese PC, Pinnschmidt HO, Reuter DA, Saugel B. Post-induction hypotension and early intraoperative hypotension associated with general anaesthesia. Br J Anaesth. 2017 Jul 1;119(1):57-64. doi: 10.1093/bja/aex127.</citation>
    <PMID>28974066</PMID>
  </reference>
  <reference>
    <citation>Blokland Y, Farquhar J, Lerou J, Mourisse J, Scheffer GJ, Geffen GJ, Spyrou L, Bruhn J. Decoding motor responses from the EEG during altered states of consciousness induced by propofol. J Neural Eng. 2016 Apr;13(2):026014. doi: 10.1088/1741-2560/13/2/026014. Epub 2016 Feb 9.</citation>
    <PMID>26859192</PMID>
  </reference>
  <reference>
    <citation>Aho AJ, Kamata K, Jäntti V, Kulkas A, Hagihira S, Huhtala H, Yli-Hankala A. Comparison of Bispectral Index and Entropy values with electroencephalogram during surgical anaesthesia with sevoflurane. Br J Anaesth. 2015 Aug;115(2):258-66. doi: 10.1093/bja/aev206. Epub 2015 Jul 1.</citation>
    <PMID>26137969</PMID>
  </reference>
  <reference>
    <citation>Sepúlveda P, Cortinez LI, Irani M, Egaña JI, Contreras V, Sánchez Corzo A, Acosta I, Sitaram R. Differential frontal alpha oscillations and mechanisms underlying loss of consciousness: a comparison between slow and fast propofol infusion rates. Anaesthesia. 2020 Feb;75(2):196-201. doi: 10.1111/anae.14885. Epub 2019 Dec 1.</citation>
    <PMID>31788791</PMID>
  </reference>
  <reference>
    <citation>Purdon PL, Sampson A, Pavone KJ, Brown EN. Clinical Electroencephalography for Anesthesiologists: Part I: Background and Basic Signatures. Anesthesiology. 2015 Oct;123(4):937-60. doi: 10.1097/ALN.0000000000000841. Review.</citation>
    <PMID>26275092</PMID>
  </reference>
  <reference>
    <citation>Fudickar A, Kluzik A, Weiler N, Scholz J, Tonner PH, Bein B. A comparison of auditory evoked potentials derived from a monitor integrated module versus standard technique. J Neurosurg Anesthesiol. 2009 Apr;21(2):120-6. doi: 10.1097/ANA.0b013e3181990d00.</citation>
    <PMID>19295390</PMID>
  </reference>
  <reference>
    <citation>Ferreira AL, Mendes JG, Nunes CS, Amorim P. [Evaluation of Bispectral Index time delay in response to anesthesia induction: an observational study]. Braz J Anesthesiol. 2019 Jul - Aug;69(4):377-382. doi: 10.1016/j.bjan.2019.03.008. Epub 2019 Jul 29. Portuguese.</citation>
    <PMID>31371175</PMID>
  </reference>
  <reference>
    <citation>Zhong Q, Chen X, Zhao Y, Liu R, Yao S. Association of Polymorphisms in Pharmacogenetic Candidate Genes with Propofol Susceptibility. Sci Rep. 2017 Jun 13;7(1):3343. doi: 10.1038/s41598-017-03229-3.</citation>
    <PMID>28611364</PMID>
  </reference>
  <reference>
    <citation>Fan J, Zhou Q, Li Y, Song X, Hu J, Qin Z, Tang J, Tao T. Profiling of Long Non-coding RNAs and mRNAs by RNA-Sequencing in the Hippocampi of Adult Mice Following Propofol Sedation. Front Mol Neurosci. 2018 Mar 23;11:91. doi: 10.3389/fnmol.2018.00091. eCollection 2018.</citation>
    <PMID>29628875</PMID>
  </reference>
  <reference>
    <citation>Hallqvist L, Mårtensson J, Granath F, Sahlén A, Bell M. Intraoperative hypotension is associated with myocardial damage in noncardiac surgery: An observational study. Eur J Anaesthesiol. 2016 Jun;33(6):450-6. doi: 10.1097/EJA.0000000000000429.</citation>
    <PMID>26950081</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 23, 2020</study_first_submitted>
  <study_first_submitted_qc>October 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 20, 2020</study_first_posted>
  <last_update_submitted>October 14, 2020</last_update_submitted>
  <last_update_submitted_qc>October 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Sixth Affiliated Hospital, Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>SanQing Jin</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>titration of propofol</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Remifentanil</mesh_term>
    <mesh_term>Rocuronium</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

